Related Experiment Video
Updated: Feb 10, 2026

06:03
Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
Published on: June 11, 2020
9.7K
[Troponin, a new myocardial infarction marker]
1Université de Liège, Service de Chimie médicale.
Revue Medicale De Liege
|December 19, 1998
Summary
Cardiac troponin T (cTnT) and troponin I (cTnI) are specific biomarkers for myocardial damage. These proteins aid in diagnosing heart attacks and other cardiac conditions with high accuracy.
Area of Science:
- Biochemistry
- Cardiology
- Immunology
Context:
- The troponin complex (Tn) comprises TnT, TnI, and TnC subunits.
- Cardiac-specific isoforms of TnT and TnI (cTnT, cTnI) are distinct from skeletal muscle isoforms.
- Immunological techniques and commercial immunoassays enable reliable detection of cTnT and cTnI.
Purpose:
- To highlight the diagnostic utility of cardiac troponins in clinical practice.
- To differentiate myocardial damage from skeletal muscle injury.
- To explore the application of cTnT and cTnI in managing acute and chronic cardiac conditions.
Summary:
- Cardiac troponin T (cTnT) and troponin I (cTnI) concentrations rise after myocardial infarction, similar to CK-MB but with a longer duration.
- Their high cardiac specificity makes them ideal for diagnosing myocardial damage in various clinical scenarios, including surgery, trauma, and exercise.
- cTnT and cTnI can detect minor myocardial damage, offering potential new applications in unstable angina management.
Impact:
- Cardiac troponins provide a reliable and specific method for diagnosing myocardial infarction and other cardiac issues.
- These biomarkers facilitate differential diagnosis between cardiac and muscular damage, improving patient management.
- The sensitivity of cTnT and cTnI expands their role in detecting subtle myocardial injury, particularly in unstable angina.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
612
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
612
In-vitro Mutagenesis
16.4K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.4K
pre-mRNA Processing
57.6K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.6K

